| | #1 |
| Administrator | New iron drug improves anemia with kidney disease Anyone see this used in their practice yet? MedlinePlus: New iron drug improves anemia with kidney disease NEW YORK (Reuters Health) - Treatment with ferumoxytol, a new iron drug that is given intravenously, is more effective against anemia than standard iron therapy, which is given by mouth, in patients with chronic kidney disease, results of a new study indicate. Anemia, which typically involves symptoms of fatigue and weakness, is common in patients with chronic kidney disease and usually relates to decreased production of a chemical that stimulates the production of red blood cells. In some patients, however, low iron levels may be a contributing factor. In the present study, Dr. Annamaria Krausz, at Tufts-New England Medical Center in Boston, and colleagues assessed the outcomes of 304 patients with kidney disease and anemia who were randomly assigned to receive two ferumoxytol doses given within 1 week or daily oral iron therapy for 21 days. About 40 percent of the subjects were also taking drugs designed to stimulate red blood cell production. Compared with oral iron therapy, treatment with ferumoxytol produced a greater increase in blood levels of hemoglobin, indicating that the drug was more effective in treating anemia. Moreover, ferumoxytol was well tolerated and less likely to cause side effects than oral iron therapy. Given its effectiveness, ferumoxytol may help patients reduce their dosage of red blood cell-stimulating drugs or avoid these agents all together. The study findings will appear in an upcoming issue of the Journal of the American Society of Nephrology. According to a press statement, AMAG Pharmaceuticals has submitted these trial results to the US Food and Drug Administration as part of a New Drug Application seeking marketing approval for ferumoxytol to treat iron deficiency anemia in patients with chronic kidney disease. SOURCE: Journal of the American Society of Nephrology, August 2008. |
| | |
| | #2 | |
| Senior Member Join Date: Apr 2007
Posts: 104
| Re: New iron drug improves anemia with kidney disease Quote:
The "chemical" ESRD patients lack is a hormone secreted by the kidneys that tells the bone marrow to produce red blood cells. Venofer has been given for >30 years without any deaths associated with it. A safe drug. Works well, doesn't need to be held for monthly labs, proven effective in helping lower Epogen doses. No test dose needed. No need for a new drug. | |
| | |
| Thread Tools | |
| Display Modes | |
| |
| | ||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| FDA expands warning on anti-anemia drugs | cougarnurse | Medication discussion | 0 | 03-10-2008 01:17 AM |
| Iron sharpening iron | The unexplainable Moo Cow | General Nursing Discussion | 1 | 11-05-2006 04:05 PM |
| Software to Help in Sickle Cell Anemia | nursebot | Nursing News | 0 | 09-15-2006 10:59 PM |
| Hospitalized hunter's condition improves | nursebot | Nursing News | 0 | 09-06-2006 12:59 PM |
| Hopsital News - Iron Mountain Helps PinnacleHealth Improve Patient Service Levels and Physician Satisfaction While Reducing Co | nursebot | Nursing News | 0 | 03-06-2006 10:59 AM |